Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Nuvo Pharmaceuticals Inc > Vimovo Litigation
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by ValueCapon Mar 15, 2021 11:37pm
231 Views
Post# 32805327

RE:Vimovo Litigation

RE:Vimovo LitigationThe litigation timeline probably got delayed a bit due to covid, but q2-3 i'm sure will be done. 

They could see a windfall payment likely for damages by DRL. 

The prospectus filing makes it faster for them to raise money quickly should they see an opportunity to acquire another product and need capital for it. Likely an end cycle high cash producing product that could be manufactured at Varennes, would be my guess. I don't think they will raise anytime soon though. 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities